Biochemistry of Atherosclerosis

About the Series:

Advances in Biochemistry in Heath and Disease presents state-of-the-art discussions in cutting-edge biochemical research, offering exciting developments that impact healthcare and disease research. Volumes in the series focus on cross-disciplinary biomedical research and examine various topics in biochemistry, cell biology, molecular biology, and biomedicine.

Biochemistry of Atherosclerosis

Sukhinder Kaur Cheema

Biochemistry of Atherosclerosis examines atherosclerosis in great detail, focusing on the risk of atherosclerosis, and the biochemical pathways involved. It provides a breadth of knowledge as well as new insights into a variety of topics relating to atherosclerosis from leading scientists around the world who are at the forefront of atherosclerosis research. Biochemistry of Atherosclerosis is essential reading for biomedical and clinical researchers.

Key topics:

• Hyperlipidaemia and Atherosclerosis

• Diabetes Induced Atherosclerosis

• Hypertension Induced Atherosclerosis

• Homocysteine Metabolism and Atherosclerosis

• Role of the Immune System in Atherosclerosis

• Role of Infectious Agents in Atherogenesis

• Dietary Management of Aherosclerosis

About the Editor:

Sukhinder Kaur Cheema is currently Associate Professor of Biochemistry and a CIHR (Canadian Institutes of Health Research) New Investigator at the Memorial University of Newfoundland. An expert in nutritional biochemistry, lipid metabolism and cardiovascular disease, she is cross appointed in Faculty of Medicine at the Memorial University of Newfoundland.

Autorentext

Dr. Sukhinder K. Cheema is Associate Professor of Biochemistry, Memorial University of Newfoundland, Canada. She has worked as a Research Scientist with the Nova-Husky Research Corporation in Alberta, Canada. She is currently researching the molecular mechanisms of cholesterol ester transfer protein regulation by dietary fats and hormones. She also researches the regulation of genes involved in cholesterol metabolism by hormone factors, the molecular basis of diabetes-accelerated atherosclerosis, and the mechanisms of lipid abnormalities caused by protease inhibitors.

Klappentext

About the Series:

Advances in Biochemistry in Heath and Disease presents state-of-the-art discussions in cutting-edge biochemical research, offering exciting developments that impact healthcare and disease research. Volumes in the series focus on cross-disciplinary biomedical research and examine various topics in biochemistry, cell biology, molecular biology, and biomedicine.

Biochemistry of Atherosclerosis

Sukhinder Kaur Cheema

Biochemistry of Atherosclerosis examines atherosclerosis in great detail, focusing on the risk of atherosclerosis, and the biochemical pathways involved. It provides a breadth of knowledge as well as new insights into a variety of topics relating to atherosclerosis from leading scientists around the world who are at the forefront of atherosclerosis research. Biochemistry of Atherosclerosis is essential reading for biomedical and clinical researchers.

Key topics:

• Hyperlipidaemia and Atherosclerosis

• Diabetes Induced Atherosclerosis

• Hypertension Induced Atherosclerosis

• Homocysteine Metabolism and Atherosclerosis

• Role of the Immune System in Atherosclerosis

• Role of Infectious Agents in Atherogenesis

• Dietary Management of Aherosclerosis

About the Editor:

Sukhinder Kaur Cheema is currently Associate Professor of Biochemistry and a CIHR (Canadian Institutes of Health Research) New Investigator at the Memorial University of Newfoundland. An expert in nutritional biochemistry, lipid metabolism and cardiovascular disease, she is cross appointed in Faculty of Medicine at the Memorial University of Newfoundland.

Zusammenfassung

At its present rate of growth, atherosclerosis will be the major cause of death from disease by the year 2020. Atherosclerosis is an extremely complex, biochemical, multifactorial process. This book will cover many aspects of atherogenesis, with particular emphasis on lipid and lipoprotein metabolism. We will cover all aspects of the regulation of cholesterol homeostasis and the importance of each pathway. This book will explore the role of nuclear hormone receptors on lipid and lipoprotein metabolism and their complex roles in atherogenesis. Finally, how the use of genetic studies can help sort out the immense complexities that mediate these aspects of atherogenesis will be discussed.

Inhalt
The role of HDL in the prevention of atherosclerosis.- Cholesterol breakdown and the significance in atherosclerosis.- Triacylglycerol hydrolase, VLDL assembly and development of atherosclerosis.- Regulation of Hepatic Production of Lipoproteins Containing Apolipoprotein B and the significance in atherosclerosis.- Dyslipidemia and thrombogenesis.- Mouse models of Diabetes and Atherosclerosis.- Role of the unfolded protein response in atherosclerosis: a potential unifying theory of atherogenesis.- SR-BI, reverse cholesterol transport and atherogenesis.- Hypertension and atherosclerosis.- Dietary fats, transcription factors and heart health.- Dietary fatty acid intake and stroke.- Homocysteine metabolism and atherosclerosis.- Vitamin supplements in preventing atherosclerosis.- Oxidized lipids and heart disease.- Reverse cholesterol transport and prevention of atherosclerosis.- Homocysteine, diabetes mellitus and atherosclerosis.- Treating low HDL-From bench to bedside.- Atherosclerosis is an infectious disease.